No Data
RxSight Cut to Hold at Stifel on Competition Concerns
Friday Opens With Falling Prices, but Market Turns Around | Live Stock
Gilead Sciences Acquires 7.85M Xilio Therapeutics Shares At $1.04 Each, Raising Ownership To Over 10%, Along With 6.1M Pre-Funded Warrants Capped At 19.99% Ownership
(GILD) - Analyzing Gilead Sciences's Short Interest
Your Healthcare Costs Are Soaring! US Spending Reached $5 Trillion In 2023 With Major Increase in Obesity and Diabetes Drugs, Hospital Services
Gilead Raises Assembly Bio Stake to ~30%